GFAP and depressive disorder: In the prefrontal cortex of human subjects with depression, the coverage of vessels by the aquaporin 4 (AQP-4)-immunoreactive endfeet of astrocytes is significantly reduced, even if the extent of those feet is not changed when labeled for the cytoskeletal protein GFAP (Rajkowska et al., 2013).